Shivam Singh, Sunita Kularia, Shivakshi Shukla, Mithilesh Singh, Manish Kumar, Ashish Kumar Sharma. (2025) A current review on animal models of anti-asthmatic drugs screening. Frontiers in Pharmacology 16.
Online publication date: 28-Jan-2025.
Crossref

Kai Pan, Qiong Li, Zhikun Guo, Zongjin Li. (2025) Healing action of Interleukin-4 (IL-4) in acute and chronic inflammatory conditions: Mechanisms and therapeutic strategies. Pharmacology & Therapeutics 265, 108760.
Online publication date: 1-Jan-2025.
Crossref

Sofi Vassileva, Peter Bonta, Els Weersink, Ian Pavord, Bart Hilvering. 2025. Biological Therapies to Treat Allergy and Asthma. Reference Module in Life Sciences.
Crossref

Irfan Ullah, Hyo Sung Choi, Changseon Choi, Kunho Chung, Jae Wook Jung, Gyeongju Yun, Seoyoun Heo, Yujong Yi, Eunhwa Kang, Sang-Heon Kim, Ho Joo Yoon, Taiyoun Rhim, Sang-Kyung Lee. (2024) Targeted siRNA delivery to lung epithelia reduces airway inflammation in a mouse model of allergic asthma. Biotechnology and Bioprocess Engineering 29:1, 97-108.
Online publication date: 21-Feb-2024.
Crossref

Avik Sarkar, Sahithi Reddy Narala, Kalpana Panati, Venkata Ramireddy Narala. 2024. Chemical therapies, immunotherapy, and new treatment strategies for allergic asthma. Allergic Asthma: Immunopathogenesis, 117-166.
Crossref

Joon-Pyo Hong, Sung Hun Kang, Jinah Chu, Sun-Ju Byeon, Hyunjoo Lee, Jeong-Hee Choi, Kyung Chul Lee, Seok Jin Hong. (2023) The Relationship Between Zonulin and Asthma: A Mouse Model Study. Journal of Rhinology 30:3, 161-166.
Online publication date: 30-Nov-2023.
Crossref

Ilja Striz, Kornel Golebski, Zuzana Strizova, Stelios Loukides, Petros Bakakos, Nicola A. Hanania, Milos Jesenak, Zuzana Diamant. (2023) New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clinical Science 137:9, 727-753.
Online publication date: 18-May-2023.
Crossref

Yuan Wu, Mengfen Huang, Jinyao Zhong, Yue Lu, Kao Gan, Rongyuan Yang, Yuntao Liu, Jiqiang Li, Jiankun Chen. (2023) The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis. Frontiers in Immunology 14.
Online publication date: 11-Apr-2023.
Crossref

Gabriele Matschiner, Mary F. Fitzgerald, Ulrich Moebius, Andreas M. Hohlbaum, Hendrik Gille, Kristian Jensen, Klaus Kirchfeld, Barbara Rattenstetter, Alice Laforge, Rachida S. Bel Aiba, Joe Ciccotosto, Hong Nyugen, Martyn L. Foster, John N. Snouwaert, MyTrang Nguyen, Beverly H. Koller, Louis Matis, Gary P. Anderson, Shane A. Olwill. (2023) Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma. Journal of Allergy and Clinical Immunology 151:4, 966-975.
Online publication date: 1-Apr-2023.
Crossref

James E. Gern, Ian D. Pavord. (2023) Challenges and Opportunities in Asthma Prevention and Treatment. The Journal of Allergy and Clinical Immunology: In Practice 11:3, 748-749.
Online publication date: 1-Mar-2023.
Crossref

Laurent Guilleminault, Eva Conde, Laurent L. Reber. (2022) Pharmacological approaches to target type 2 cytokines in asthma. Pharmacology & Therapeutics 237, 108167.
Online publication date: 1-Sep-2022.
Crossref

, Hugo A Farne, Amanda Wilson, Stephen Milan, Emma Banchoff, Freda Yang, Colin VE Powell. (2022) Anti-IL-5 therapies for asthma. Cochrane Database of Systematic Reviews 2022:7.
Online publication date: 12-Jul-2022.
Crossref

Mala Upadhyay, Antoine Nehme, Samiksha Wasnik. (2022) Title-Inflammatory Signaling Pathways in Allergic and Infection-Associated Lung Diseases. Allergies 2:2, 57-74.
Online publication date: 1-Jun-2022.
Crossref

Richard T. AMISON, Clive P. PAGE. (2022) Novel pharmacological therapies for the treatment of bronchial asthma. Minerva Medica 113:1.
Online publication date: 1-Feb-2022.
Crossref

Brittany Salter, Paige Lacy, Manali Mukherjee. (2022) Biologics in Asthma: A Molecular Perspective to Precision Medicine. Frontiers in Pharmacology 12.
Online publication date: 19-Jan-2022.
Crossref

Simon Couillard, Ian D. Pavord. 2022. Biological Therapies for Asthma. Encyclopedia of Respiratory Medicine, 411-434.
Crossref

Luciana Pádua Tavares, Izabela Galvão, Maximiliano R Ferrero. 2022. Novel Immunomodulatory Therapies for Respiratory Pathologies. Comprehensive Pharmacology, 554-594.
Crossref

Soyoon Sim, Youngwoo Choi, Hae-Sim Park. (2022) Immunologic Basis of Type 2 Biologics for Severe Asthma. Immune Network 22:6.
Online publication date: 1-Jan-2022.
Crossref

Siti Muhamad Nur Husna, Norasnieda Md Shukri, Noor Suryani Mohd Ashari, Kah Keng Wong. (2022) IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma. PeerJ 10, e13444.
Online publication date: 30-May-2022.
Crossref

, Andrew Gallagher, Michaela Edwards, Parameswaran Nair, Stewart Drew, Aashish Vyas, Rashmi Sharma, Paul A Marsden, Ran Wang, David JW Evans. (2021) Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma. Cochrane Database of Systematic Reviews 2021:10.
Online publication date: 19-Oct-2021.
Crossref

Dominick E Shaw, Liam G Heaney, Mike Thomas, Richard Beasley, Peter G Gibson, Ian D Pavord. (2021) Balancing the needs of the many and the few: where next for adult asthma guidelines?. The Lancet Respiratory Medicine 9:7, 786-794.
Online publication date: 1-Jul-2021.
Crossref

Norihiro Harada, Jun Ito, Kazuhisa Takahashi. (2021) Clinical effects and immune modulation of biologics in asthma. Respiratory Investigation 59:4, 389-396.
Online publication date: 1-Jul-2021.
Crossref

Klimek L, Hagemann J, Casper I, Huppertz T, Bedbrook A, Bousquet J. (2021) Immunological background for treatments with biologicals in CRSwNP. Archives of Asthma, Allergy and Immunology 5:1, 022-029.
Online publication date: 8-Apr-2021.
Crossref

Beatriz León, Andre Ballesteros-Tato. (2021) Modulating Th2 Cell Immunity for the Treatment of Asthma. Frontiers in Immunology 12.
Online publication date: 10-Feb-2021.
Crossref

Nozomi Tani, Nobutaka Kataoka, Yusuke Kunimatsu, Yusuke Tachibana, Takumi Sugimoto, Izumi Sato, Yuri Ogura, Kazuki Hirose, Takayuki Takeda. (2021) Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study. Multidisciplinary Respiratory Medicine 16.
Online publication date: 17-Mar-2021.
Crossref

Archita Ray, Sabita Singh, Joytri Dutta, Ulaganathan Mabalirajan. 2021. Targeting Molecular and Cellular Mechanisms in Asthma. Targeting Cellular Signalling Pathways in Lung Diseases, 27-51.
Crossref

John Foerster, Aleksandra Molęda. (2020) Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis. Viruses 12:4, 438.
Online publication date: 13-Apr-2020.
Crossref

Angela Moran, Ian D Pavord. (2020) Anti-IL-4/IL-13 for the treatment of asthma: the story so far. Expert Opinion on Biological Therapy 20:3, 283-294.
Online publication date: 20-Jan-2020.
Crossref

Julie K. Nguyen, Evan Austin, Alisen Huang, Andrew Mamalis, Jared Jagdeo. (2020) The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Archives of Dermatological Research 312:2, 81-92.
Online publication date: 6-Sep-2019.
Crossref

Michael C Peters, Sally E Wenzel. (2020) Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. The Lancet 395:10221, 371-383.
Online publication date: 1-Feb-2020.
Crossref

N.O. Pereverzina, L.S. Kruglova, I.E. Musaev. (2020) Present and future in the treatment of chronic spontaneous urticaria. Klinicheskaya dermatologiya i venerologiya 19:5, 604.
Online publication date: 1-Jan-2020.
Crossref

Ludger Klimek, Boris A. Stuck, Barbara Wollenberg. (2020) Chronische Rhinosinusitis mit Nasenpolypen: Biologika auf dem Prüfstand. Deutsches Ärzteblatt Online.
Online publication date: 14-Feb-2020.
Crossref

O. M. Kurbacheva, M. A. Galitskaya. (2019) The place of Omalizumab in the treatment of allergic diseases. Medical Council:15, 38-49.
Online publication date: 8-Dec-2019.
Crossref

Babak Aberumand, Anne K. Ellis. (2019) Asthma and the Biologics Revolution, Part 2: Failures and the Future Potential. Current Treatment Options in Allergy 6:4, 468-492.
Online publication date: 16-Nov-2019.
Crossref

Jung-Eun Kim, Keunok Jung, Jeong-Ah Kim, Seung-Hyun Kim, Hae-Sim Park, Yong-Sung Kim. (2019) Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity. Scientific Reports 9:1.
Online publication date: 23-May-2019.
Crossref

Yorihiko Kyogoku, Hisatoshi Sugiura, Tomohiro Ichikawa, Tadahisa Numakura, Akira Koarai, Mitsuhiro Yamada, Naoya Fujino, Yutaka Tojo, Katsuhiro Onodera, Rie Tanaka, Kei Sato, Hirohito Sano, Shun Yamanaka, Koji Itakura, Ayumi Mitsune, Tsutomu Tamada, Takaaki Akaike, Masakazu Ichinose. (2019) Nitrosative stress in patients with asthma–chronic obstructive pulmonary disease overlap. Journal of Allergy and Clinical Immunology 144:4, 972-983.e14.
Online publication date: 1-Oct-2019.
Crossref

Ian D. Pavord, Rahul Shrimanker, Nicola A. Hanania. 2019. Biologics targeting type 2 inflammation in severe asthma. Severe Asthma.
Crossref

Matshediso C. Mokoka, Melissa J. McDonnell, Elaine MacHale, Breda Cushen, Fiona Boland, Sarah Cormican, Christina Doherty, Frank Doyle, Richard W. Costello, Garrett Greene. (2019) Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study. European Respiratory Journal 53:5, 1802161.
Online publication date: 7-Mar-2019.
Crossref

Bart N. Lambrecht, Hamida Hammad, John V. Fahy. (2019) The Cytokines of Asthma. Immunity 50:4, 975-991.
Online publication date: 1-Apr-2019.
Crossref

Willem van de Veen, Mübeccel Akdis. (2019) The use of biologics for immune modulation in allergic disease. Journal of Clinical Investigation 129:4, 1452-1462.
Online publication date: 18-Mar-2019.
Crossref

R. Stokes Peebles, Mark A. Aronica. (2019) Proinflammatory Pathways in the Pathogenesis of Asthma. Clinics in Chest Medicine 40:1, 29-50.
Online publication date: 1-Mar-2019.
Crossref

Mary Clare McGregor, James G. Krings, Parameswaran Nair, Mario Castro. (2019) Role of Biologics in Asthma. American Journal of Respiratory and Critical Care Medicine 199:4, 433-445.
Online publication date: 15-Feb-2019.
Abstract | Full Text | PDF (1346 KB) | Supplemental Material 

Jae Seok Jeong, So Ri Kim, Seong Ho Cho, Yong Chul Lee. (2019) A Novel Insight on Endotyping Heterogeneous Severe Asthma Based on Endoplasmic Reticulum Stress: Beyond the “Type 2/Non-Type 2 Dichotomy”. International Journal of Molecular Sciences 20:3, 713.
Online publication date: 7-Feb-2019.
Crossref

L. Klimek, M. Koennecke, J. Hagemann, B. Wollenberg, S. Becker. (2019) Immunologie der Polyposis nasi als Grundlage für eine Therapie mit Biologicals. HNO 67:1, 15-26.
Online publication date: 30-Aug-2018.
Crossref

Kamyar M. Hedayat, Jean-Claude Lapraz. 2019. Asthma: An integrative physiologic approach. The Theory of Endobiogeny, 23-53.
Crossref

Olga Danov, Sharon Melissa Jiménez Delgado, Helena Obernolte, Sophie Seehase, Susann Dehmel, Peter Braubach, Hans-Gerd Fieguth, Gabriele Matschiner, Mary Fitzgerald, Danny Jonigk, Sascha Knauf, Olaf Pfennig, Gregor Warnecke, Judy Wichmann, Armin Braun, Katherina Sewald, Hong Wei Chu. (2018) Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs. PLOS ONE 13:11, e0207767.
Online publication date: 30-Nov-2018.
Crossref

Wirach Chitsuthipakorn, Kachorn Seresirikachorn, Doron D. Sommer, Tobial McHugh, Kornkiat Snidvongs. (2018) Endotypes of Chronic Rhinosinusitis Across Ancestry and Geographic Regions. Current Allergy and Asthma Reports 18:9.
Online publication date: 11-Jul-2018.
Crossref

Gail M. Gauvreau, Beth E. Davis, John Paul Oliveria. 2018. Inhaled Antisense for Treatment of Respiratory Disease. Oligonucleotide‐Based Drugs and Therapeutics, 355-388.
Crossref

Danielle Karo-Atar, Almog Bitton, Itai Benhar, Ariel Munitz. (2018) Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond. BioDrugs 32:3, 201-220.
Online publication date: 7-May-2018.
Crossref

Martin Braddock, Nicola A. Hanania, Amir Sharafkhaneh, Gene Colice, Mats Carlsson. (2018) Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. Drug Safety 41:5, 489-509.
Online publication date: 6-Feb-2018.
Crossref

Juliana Barrios, Xingbin Ai. (2018) Neurotrophins in Asthma. Current Allergy and Asthma Reports 18:2.
Online publication date: 16-Feb-2018.
Crossref

So Ri Kim. 2018. Pharmacologic Therapies for Severe Asthma. Severe Asthma, 99-122.
Crossref

Fang Chen, Jia-Ying Zhang, Hong-Kuan Yang, Fang Wang. 2018. Asthma Precision. Genomic Approach to Asthma, 361-385.
Crossref

Jae Seok Jeong, So Ri Kim, Seong Ho Cho, Yong Chul Lee. (2017) Endoplasmic Reticulum Stress and Allergic Diseases. Current Allergy and Asthma Reports 17:12.
Online publication date: 8-Nov-2017.
Crossref

Hugo A Farne, Amanda Wilson, Colin Powell, Lynne Bax, Stephen J Milan, . (2017) Anti-IL5 therapies for asthma. Cochrane Database of Systematic Reviews 44.
Online publication date: 21-Sep-2017.
Crossref

Michael Wegmann. (2017) Targeting cytokines in asthma therapy: could IL-37 be a solution?. Expert Review of Respiratory Medicine 11:9, 675-677.
Online publication date: 17-Jul-2017.
Crossref

Peter A. Tauber, Winfried F. Pickl. (2017) Pharmacological targeting of allergen-specific T lymphocytes. Immunology Letters 189, 27-39.
Online publication date: 1-Sep-2017.
Crossref

Seyyed Shamsadin Athari, Seyyede Masoume Athari, Fateme Beyzay, Masoud Movassaghi, Esmaeil Mortaz, Mehdi Taghavi. (2017) Critical role of Toll-like receptors in pathophysiology of allergic asthma. European Journal of Pharmacology 808, 21-27.
Online publication date: 1-Aug-2017.
Crossref

Fedoseev GB. (2017) The Role of Cytokines in the Pathogenesis of Bronchial Asthma and the Possibilities of Anti-Cytokine Therapy. Journal of Lung, Pulmonary & Respiratory Research 4:4.
Online publication date: 27-Jul-2017.
Crossref

Catherine S. Tripp, Carolyn Cuff, Andrew L. Campbell, Barbara A. Hendrickson, Jeff Voss, Terry Melim, Chengbin Wu, Andrew D. Cherniack, Kenneth Kim. (2017) RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study. Advances in Therapy 34:6, 1364-1381.
Online publication date: 28-Apr-2017.
Crossref

Matthew Loxham, Donna E. Davies. (2017) Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients. Journal of Allergy and Clinical Immunology 139:6, 1736-1751.
Online publication date: 1-Jun-2017.
Crossref

Namita A. Gandhi, Gianluca Pirozzi, Neil M. H. Graham. (2017) Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Review of Clinical Immunology 13:5, 425-437.
Online publication date: 15-Mar-2017.
Crossref

Giuseppe Santini, Nadia Mores, Mario Malerba, Chiara Mondino, Roberta Anzivino, Giuseppe Macis, Paolo Montuschi. (2017) Dupilumab for the treatment of asthma. Expert Opinion on Investigational Drugs 26:3, 357-366.
Online publication date: 7-Feb-2017.
Crossref

Maria Theresa D. Opina, Wendy C. Moore. (2017) Phenotype-Driven Therapeutics in Severe Asthma. Current Allergy and Asthma Reports 17:2.
Online publication date: 23-Feb-2017.
Crossref

Hun Soo Chang, Tae-Hyeong Lee, Ji Ae Jun, Ae Rin Baek, Jong-Sook Park, So-My Koo, Yang- Ki Kim, Ho Sung Lee, Choon-Sik Park. (2017) Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations. Expert Review of Respiratory Medicine 11:1, 29-40.
Online publication date: 15-Dec-2016.
Crossref

Ulrich M. Zissler. 2017. Specific Therapies for Asthma Endotypes: A New Twist in Drug Development. Allergy Prevention and Exacerbation, 209-238.
Crossref

Linda Swedin, Tiiu Saarne, Maria Rehnberg, Pernilla Glader, Magdalena Niedzielska, Gustav Johansson, Petra Hazon, Matthew C. Catley. (2017) Patient stratification and the unmet need in asthma. Pharmacology & Therapeutics 169, 13-34.
Online publication date: 1-Jan-2017.
Crossref

I. P. Shilovskiy, D. V. Eroshkina, A. A. Babakhin, M. R. Khaitov. (2017) Anticytokine therapy of allergic asthma. Molecular Biology 51:1, 1-13.
Online publication date: 23-Feb-2017.
Crossref

Merritt L. Fajt, Sally E. Wenzel. (2017) Development of New Therapies for Severe Asthma. Allergy, Asthma & Immunology Research 9:1, 3.
Online publication date: 1-Jan-2017.
Crossref

G B Fedoseev, V I Trofimov, K V Negrutsa, V G Timchik, V I Golubeva, V A Aleksandrin, T S Razumovskaya, K N Kryakunov. (2016) Regarding to the issue of the role of cytokines in the pathogenesis of asthma and the possibilities of anticytokine therapy. Russian Journal of Allergy 13:6, 23-36.
Online publication date: 15-Dec-2016.
Crossref

Andrea C Valladao, Charles W Frevert, Lisa K Koch, Daniel J Campbell, Steven F Ziegler. (2016) STAT6 Regulates the Development of Eosinophilic versus Neutrophilic Asthma in Response to Alternaria alternata. The Journal of Immunology 197:12, 4541-4551.
Online publication date: 15-Dec-2016.
Crossref

Amy Chang, Ynuk Bossé. (2016) Targeting Single Molecules in Asthma Benefits Few. Trends in Molecular Medicine 22:11, 935-945.
Online publication date: 1-Nov-2016.
Crossref

Diane Wang, Lisa A. Beck. (2016) Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update. American Journal of Clinical Dermatology 17:5, 425-443.
Online publication date: 1-Jul-2016.
Crossref

Rabih Halwani, Asma Sultana Shaik, Elaref Ratemi, Sibtain Afzal, Rosan Kenana, Saleh Al-Muhsen, Achraf Al Faraj. (2016) A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma. Experimental & Molecular Medicine 48:10, e262-e262.
Online publication date: 7-Oct-2016.
Crossref

Kent Lam, Robert C. Kern, Amber Luong. (2016) Is there a future for biologics in the management of chronic rhinosinusitis?. International Forum of Allergy & Rhinology 6:9, 935-942.
Online publication date: 22-Apr-2016.
Crossref

Larry Borish. (2016) The immunology of asthma. Annals of Allergy, Asthma & Immunology 117:2, 108-114.
Online publication date: 1-Aug-2016.
Crossref

Ian D. Pavord, Bart Hilvering, Rahul Shrimanker. (2016) Emerging Biologics in Severe Asthma. Immunology and Allergy Clinics of North America 36:3, 609-623.
Online publication date: 1-Aug-2016.
Crossref

Achraf Al Faraj, Asma Sultana Shaik, Sibtain Afzal, Saleh Al‐Muhsen, Rabih Halwani. (2016) Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers. Contrast Media & Molecular Imaging 11:3, 172-183.
Online publication date: 28-Dec-2015.
Crossref

Melissa H. Bloodworth, Dawn C. Newcomb, Daniel E. Dulek, Matthew T. Stier, Jacqueline Y. Cephus, Jian Zhang, Kasia Goleniewska, Jay K. Kolls, R. Stokes Peebles, S. Ehrt. (2016) STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection. Infection and Immunity 84:5, 1548-1555.
Online publication date: 1-May-2016.
Crossref

Panida Sriaroon, Mark Ballow. (2016) Biological Modulators in Eosinophilic Diseases. Clinical Reviews in Allergy & Immunology 50:2, 252-272.
Online publication date: 17-Aug-2014.
Crossref

Gilda Varricchi, Diego Bagnasco, Francesco Borriello, Enrico Heffler, Giorgio W. Canonica. (2016) Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders. Current Opinion in Allergy & Clinical Immunology 16:2, 186-200.
Online publication date: 1-Apr-2016.
Crossref

Hesham Raafat. (2016) Biological therapy in severe asthma: A gem or a jam. Egyptian Journal of Bronchology 10:1, 1-4.
Online publication date: 17-Feb-2016.
Crossref

Kara Vale. (2016) Targeting the Jak-Stat Pathway in the Treatment of ‘Th2-High’ Severe Asthma. Future Medicinal Chemistry 8:4, 405-419.
Online publication date: 2-Mar-2016.
Crossref

Jimena Perez-Lloret, Isobel S. Okoye, Riccardo Guidi, Yashaswini Kannan, Stephanie M. Coomes, Stephanie Czieso, Gabrielle Mengus, Irwin Davidson, Mark S. Wilson. (2016) T-cell–intrinsic Tif1α/Trim24 regulates IL-1R expression on T _H 2 cells and T _H 2 cell-mediated airway allergy. Proceedings of the National Academy of Sciences 113:5.
Online publication date: 19-Jan-2016.
Crossref

Kian Fan Chung. (2016) Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. Journal of Internal Medicine 279:2, 192-204.
Online publication date: 15-Jun-2015.
Crossref

Tracy L Staton, David F Choy, Joseph R Arron. (2016) Biomarkers in the Clinical Development of Asthma Therapies. Biomarkers in Medicine 10:2, 165-176.
Online publication date: 14-Jan-2016.
Crossref

Laura De Ferrari, Alessandra Chiappori, Diego Bagnasco, Anna Maria Riccio, Giovanni Passalacqua, Giorgio Walter Canonica. (2016) Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?. Expert Review of Respiratory Medicine 10:1, 29-38.
Online publication date: 13-Nov-2015.
Crossref

PD Mitchell, AI El‐Gammal, PM O'Byrne. (2016) Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma. Clinical Pharmacology & Therapeutics 99:1, 38-48.
Online publication date: 18-Nov-2015.
Crossref

Patrick D. Mitchell, Amani I. El-Gammal, Paul M. O’Byrne. 2016. Anti-IgE and Biologic Approaches for the Treatment of Asthma. Pharmacology and Therapeutics of Asthma and COPD, 131-152.
Crossref

Chrysanthi Skevaki, Christoph Hudemann, Harald Renz. 2016. Interleukin 4 and the Related Cytokines (Interleukin 5 and Interleukin 13). Compendium of Inflammatory Diseases, 678-686.
Crossref

Fernando O. Martinez Estrada, Siamon Gordon. 2016. The Cellular and Molecular Network of IL-4 and IL-13. Encyclopedia of Immunobiology, 519-524.
Crossref

Bart Hilvering, Ian D. Pavord. 2016. Biologicals to Treat Allergy and Asthma. Encyclopedia of Immunobiology, 321-327.
Crossref

Andrew L. Durham, Gaetano Caramori, Kian F. Chung, Ian M. Adcock. (2016) Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease. Translational Research 167:1, 192-203.
Online publication date: 1-Jan-2016.
Crossref

Namita A. Gandhi, Brandy L. Bennett, Neil M. H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos. (2016) Targeting key proximal drivers of type 2 inflammation in disease. Nature Reviews Drug Discovery 15:1, 35-50.
Online publication date: 16-Oct-2015.
Crossref

Nestor A Molfino, Piotr Kuna, Jonathan A Leff, Chad K Oh, Dave Singh, Marlene Chernow, Brian Sutton, Geoffrey Yarranton. (2016) Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma. BMJ Open 6:1, e007709.
Online publication date: 6-Jan-2016.
Crossref

Giorgio Walter Canonica, Gianenrico Senna, Patrick D. Mitchell, Paul M. O’Byrne, Giovanni Passalacqua, Gilda Varricchi. (2016) Therapeutic interventions in severe asthma. World Allergy Organization Journal 9, 40.
Online publication date: 1-Jan-2016.
Crossref

Mitsunari NAKAJIMA, Minetaro OGAWA, Yoshiaki AMAKURA, Morio YOSHIMURA, Satoshi OKUYAMA, Yoshiko FURUKAWA. (2016) 3,5,6,7,8,3’,4’-Heptamethoxyflavone reduces interleukin-4 production in the spleen cells of mice . Biomedical Research 37:2, 95-99.
Online publication date: 1-Jan-2016.
Crossref

Kenji Izuhara, Shoichiro Ohta, Junya Ono. (2016) Using Periostin as a Biomarker in the Treatment of Asthma. Allergy, Asthma & Immunology Research 8:6, 491.
Online publication date: 1-Jan-2016.
Crossref

Peng Gao, Peter G Gibson, Katherine J Baines, Ian A Yang, John W Upham, Paul N Reynolds, Sandra Hodge, Alan L James, Christine Jenkins, Matthew J Peters, Jie Zhang, Jodie L Simpson. (2015) Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β. Respiratory Research 16:1.
Online publication date: 24-Jan-2015.
Crossref

Marc Gauthier, Anuradha Ray, Sally E. Wenzel. (2015) Evolving Concepts of Asthma. American Journal of Respiratory and Critical Care Medicine 192:6, 660-668.
Online publication date: 15-Sep-2015.
Abstract | Full Text | PDF (779 KB) | Supplemental Material 

Kian Fan Chung. (2015) Targeting the interleukin pathway in the treatment of asthma. The Lancet 386:9998, 1086-1096.
Online publication date: 1-Sep-2015.
Crossref

Kenji Izuhara, Hisako Matsumoto, Shoichiro Ohta, Junya Ono, Kazuhiko Arima, Masahiro Ogawa. (2015) Recent developments regarding periostin in bronchial asthma. Allergology International 64, S3-S10.
Online publication date: 1-Sep-2015.
Crossref

Richard D. May, Michael Fung. (2015) Strategies targeting the IL-4/IL-13 axes in disease. Cytokine 75:1, 89-116.
Online publication date: 1-Sep-2015.
Crossref

Sarah M. McCormick, Nicola M. Heller. (2015) Commentary: IL-4 and IL-13 receptors and signaling. Cytokine 75:1, 38-50.
Online publication date: 1-Sep-2015.
Crossref

T. B. Casale, J. Cole, E. Beck, C. F. Vogelmeier, J. Willers, C. Lassen, A. Hammann‐Haenni, L. Trokan, P. Saudan, M. E. Wechsler. (2015) CYT 003, a TLR 9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study. Allergy 70:9, 1160-1168.
Online publication date: 22-Jun-2015.
Crossref

Bruce S. Bochner. (2015) Novel Therapies for Eosinophilic Disorders. Immunology and Allergy Clinics of North America 35:3, 577-598.
Online publication date: 1-Aug-2015.
Crossref

Colin Powell, Stephen J Milan, Kerry Dwan, Lynne Bax, Nicola Walters, Colin Powell. 2015. Mepolizumab versus placebo for asthma. Cochrane Database of Systematic Reviews.
Crossref

O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt‐Weber, H.‐U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis, F. Spertini. (2015) EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 70:7, 727-754.
Online publication date: 24-Apr-2015.
Crossref

B. Hilvering, I. D. Pavord. (2015) What goes up must come down: biomarkers and novel biologicals in severe asthma. Clinical & Experimental Allergy 45:7, 1162-1169.
Online publication date: 17-Jun-2015.
Crossref

Hui-ying Wang, Yu Dai, Jiao-li Wang, Xu-yan Yang, Xin-guo Jiang. (2015) Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma. Journal of Zhejiang University-SCIENCE B 16:7, 622-631.
Online publication date: 12-Jul-2015.
Crossref

Lisa Giovannini-Chami, Marc Albertini, Pierre Scheinmann, Jacques de Blic. (2015) New insights into the treatment of severe asthma in children. Paediatric Respiratory Reviews 16:3, 167-173.
Online publication date: 1-Jun-2015.
Crossref

Norbert Krug, Jens M. Hohlfeld, Anne-Marie Kirsten, Oliver Kornmann, Kai M. Beeh, Dominik Kappeler, Stephanie Korn, Stanislav Ignatenko, Wolfgang Timmer, Cordelia Rogon, Jana Zeitvogel, Nan Zhang, Joachim Bille, Ursula Homburg, Agnieszka Turowska, Claus Bachert, Thomas Werfel, Roland Buhl, Jonas Renz, Holger Garn, Harald Renz. (2015) Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme. New England Journal of Medicine 372:21, 1987-1995.
Online publication date: 21-May-2015.
Crossref

Carolina Cisneros Serrano, Carlos Melero Moreno, Carlos Almonacid Sánchez, Miguel Perpiñá Tordera, César Picado Valles, Eva Martínez Moragón, Luis Pérez de Llano, José Gregorio Soto Campos, Isabel Urrutia Landa, Gloria García Hernández. (2015) Guidelines for Severe Uncontrolled Asthma. Archivos de Bronconeumología (English Edition) 51:5, 235-246.
Online publication date: 1-May-2015.
Crossref

Carolina Cisneros Serrano, Carlos Melero Moreno, Carlos Almonacid Sánchez, Miguel Perpiñá Tordera, César Picado Valles, Eva Martínez Moragón, Luis Pérez de Llano, José Gregorio Soto Campos, Isabel Urrutia Landa, Gloria García Hernández. (2015) Normativa sobre asma grave no controlada. Archivos de Bronconeumología 51:5, 235-246.
Online publication date: 1-May-2015.
Crossref

Bauke Pauwels, Karin Jonstam, Claus Bachert. (2015) Emerging biologics for the treatment of chronic rhinosinusitis. Expert Review of Clinical Immunology 11:3, 349-361.
Online publication date: 5-Feb-2015.
Crossref

Paul A. Greenberger. (2015) Will a nasal corticosteroid improve control for patients with step 3 or higher persistent asthma?. Journal of Allergy and Clinical Immunology 135:3, 710-711.
Online publication date: 1-Mar-2015.
Crossref

Jared Darveaux, William W. Busse. (2015) Biologics in Asthma—The Next Step Toward Personalized Treatment. The Journal of Allergy and Clinical Immunology: In Practice 3:2, 152-160.
Online publication date: 1-Mar-2015.
Crossref

Fanny Legrand, Amy D. Klion. (2015) Biologic Therapies Targeting Eosinophils: Current Status and Future Prospects. The Journal of Allergy and Clinical Immunology: In Practice 3:2, 167-174.
Online publication date: 1-Mar-2015.
Crossref

Merritt L. Fajt, Sally E. Wenzel. (2015) Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care. Journal of Allergy and Clinical Immunology 135:2, 299-310.
Online publication date: 1-Feb-2015.
Crossref

Rebecca N. Bauer, Monali Manohar, Anne Marie Singh, David C. Jay, Kari C. Nadeau. (2015) The future of biologics: Applications for food allergy. Journal of Allergy and Clinical Immunology 135:2, 312-323.
Online publication date: 1-Feb-2015.
Crossref

Humberto E. Trejo Bittar, Samuel A. Yousem, Sally E. Wenzel. (2015) Pathobiology of Severe Asthma. Annual Review of Pathology: Mechanisms of Disease 10:1, 511-545.
Online publication date: 24-Jan-2015.
Crossref

Anuradha Ray, Timothy B. Oriss, Sally E. Wenzel. (2015) Emerging molecular phenotypes of asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology 308:2, L130-L140.
Online publication date: 15-Jan-2015.
Crossref

Giovanni B Pajno, Kari C Nadeau, Giovanni Passalacqua, Lucia Caminiti, Ben Hobson, David C Jay, Stefania Arasi, Fernanda Chiera, Giuseppina Salzano. (2015) The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook. Expert Review of Clinical Immunology 11:1, 141-154.
Online publication date: 2-Dec-2014.
Crossref

RM Dunn, ME Wechsler. (2015) Anti‐Interleukin Therapy in Asthma. Clinical Pharmacology & Therapeutics 97:1, 55-65.
Online publication date: 15-Dec-2014.
Crossref

Stefanie C.M. Burleson, Robert B. Fick, Mark D. Mannie, Stephen G. Olmstead, Michael R. Van Scott. 2015. The Immune Basis of Allergic Lung Disease. Comparative Biology of the Normal Lung, 683-719.
Crossref

Yuka Hiroshima, Linda Garthwaite, Kenneth Hsu, Hyouna Yoo, Sang-Ho Park, Carolyn L. Geczy, Rakesh K. Kumar, Cristan Herbert, Sandra Helena Penha Oliveira. (2015) ISU201 Enhances the Resolution of Airway Inflammation in a Mouse Model of an Acute Exacerbation of Asthma. Mediators of Inflammation 2015:1.
Online publication date: 12-Feb-2015.
Crossref

Sonja Koch, Susetta Finotto. (2015) Role of Interferon-λ in Allergic Asthma. Journal of Innate Immunity 7:3, 224-230.
Online publication date: 15-Jan-2015.
Crossref

Gabriele Grunig, Aram Baghdassarian, Sung-Hyun Park, Serhiy Pylawka, Bertram Bleck, Joan Reibman, Erika Berman-Rosenzweig, Nedim Durmus. (2015) Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs. Biomarker Insights 10s4, BMI.S29514.
Online publication date: 16-Feb-2016.
Crossref

Els De Schryver, Lien Devuyst, Lara Derycke, Melissa Dullaers, Thibaut Van Zele, Claus Bachert, Philippe Gevaert. (2015) Local Immunoglobulin E in the Nasal Mucosa: Clinical Implications. Allergy, Asthma & Immunology Research 7:4, 321.
Online publication date: 1-Jan-2015.
Crossref

Lawren C Wu, Heleen Scheerens. (2014) Targeting IgE production in mice and humans. Current Opinion in Immunology 31, 8-15.
Online publication date: 1-Dec-2014.
Crossref

Andrew L. Kau, Phillip E. Korenblat. (2014) Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes. Current Opinion in Allergy & Clinical Immunology 14:6, 570-575.
Online publication date: 1-Dec-2014.
Crossref

Frank R. Brennan. 2014. MAbs Targeting Soluble Mediators in Phase 1 and 2 Clinical Studies Immunological Disorders. Handbook of Therapeutic Antibodies, 969-1078.
Crossref

N Voraphani, M T Gladwin, A U Contreras, N Kaminski, J R Tedrow, J Milosevic, E R Bleecker, D A Meyers, A Ray, P Ray, S C Erzurum, W W Busse, J Zhao, J B Trudeau, S E Wenzel. (2014) An airway epithelial iNOS–DUOX2–thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma. Mucosal Immunology 7:5, 1175-1185.
Online publication date: 1-Sep-2014.
Crossref

P. J. Barnes, T. B. Casale, R. Dahl, I. D. Pavord, M. E. Wechsler. (2014) The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use. Allergy 69:9, 1119-1140.
Online publication date: 15-Jul-2014.
Crossref

Merritt L. Fajt, Sally E. Wenzel. (2014) Biologic therapy in asthma: entering the new age of personalized medicine. Journal of Asthma 51:7, 669-676.
Online publication date: 13-May-2014.
Crossref

Musa R. Khaitov, Igor P. Shilovskiy, Aleksandra A. Nikonova, Nadezda N. Shershakova, Oleg Y. Kamyshnikov, Alexander A. Babakhin, Vitaly V. Zverev, Sebastian L. Johnston, Rakhim M. Khaitov. (2014) Small Interfering RNAs Targeted to Interleukin-4 and Respiratory Syncytial Virus Reduce Airway Inflammation in a Mouse Model of Virus-Induced Asthma Exacerbation. Human Gene Therapy 25:7, 642-650.
Online publication date: 1-Jul-2014.
Crossref

Willem van de Veen, Mübeccel Akdis. (2014) New Targets for Immune Modulation in Asthma. Current Treatment Options in Allergy 1:2, 171-185.
Online publication date: 30-Jan-2014.
Crossref

Kian Fan Chung. (2014) Defining Phenotypes in Asthma: A Step Towards Personalized Medicine. Drugs 74:7, 719-728.
Online publication date: 6-May-2014.
Crossref

Ensaf A. Azazi, Ashraf E. Elshora, Enas A. Tantawy, Marwa A. Elsayd. (2014) Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients. Egyptian Journal of Chest Diseases and Tuberculosis 63:2, 279-284.
Online publication date: 1-Apr-2014.
Crossref

Martin J. Romeo, Rachana Agrawal, Anna Pomés, Judith A. Woodfolk. (2014) A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease. Journal of Allergy and Clinical Immunology 133:4, 952-960.e1.
Online publication date: 1-Apr-2014.
Crossref

Erika H. De Boever, Claire Ashman, Anthony P. Cahn, Nicholas W. Locantore, Phil Overend, Isabelle J. Pouliquen, Adrian P. Serone, Tracey J. Wright, Mair M. Jenkins, Inderpal S. Panesar, Sivayogan S. Thiagarajah, Sally E. Wenzel. (2014) Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial. Journal of Allergy and Clinical Immunology 133:4, 989-996.e4.
Online publication date: 1-Apr-2014.
Crossref

Michael C. Peters, Zesemayat K. Mekonnen, Shaopeng Yuan, Nirav R. Bhakta, Prescott G. Woodruff, John V. Fahy. (2014) Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. Journal of Allergy and Clinical Immunology 133:2, 388-394.e5.
Online publication date: 1-Feb-2014.
Crossref

Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jarjour, Thais Mauad, Ronald L. Sorkness, W. Gerald Teague. (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. European Respiratory Journal 43:2, 343-373.
Online publication date: 12-Dec-2013.
Crossref

Swati Agrawal, Robert G Townley. (2014) Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma. Expert Opinion on Biological Therapy 14:2, 165-181.
Online publication date: 28-Nov-2013.
Crossref

Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters, Parameswaran Nair, . (2014) Omalizumab for asthma in adults and children. Cochrane Database of Systematic Reviews 2014:1.
Online publication date: 13-Jan-2014.
Crossref

Chrysanthi Skevaki, Christoph Hudemann, Harald Renz. 2014. Interleukin 4 and the Related Cytokines (Interleukin 5 and Interleukin 13). Encyclopedia of Inflammatory Diseases, 1-9.
Crossref

Joseph R. Arron, Jeffrey M. Harris. 2014. Molecular Heterogeneity, Biomarker Discovery, and Targeted Therapy in Asthma. Genomic Biomarkers for Pharmaceutical Development, 73-94.
Crossref

John W. Steinke, Lanny J. Rosenwasser, Larry Borish. 2014. Cytokines in Allergic Inflammation. Middleton's Allergy, 65-82.
Crossref

Christopher E. Brightling, Dhananjay Desai, Ian D. Pavord. 2014. Cytokine-Specific Therapy in Asthma. Middleton's Allergy, 1491-1502.
Crossref

Nathan Hambly, Parameswaran Nair. (2014) Monoclonal antibodies for the treatment of refractory asthma. Current Opinion in Pulmonary Medicine 20:1, 87-94.
Online publication date: 1-Jan-2014.
Crossref

H. Scheerens, J. R. Arron, Y. Zheng, W. S. Putnam, R. W. Erickson, D. F. Choy, J. M. Harris, J. Lee, N. N. Jarjour, J. G. Matthews. (2014) The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clinical & Experimental Allergy 44:1, 38-46.
Online publication date: 20-Dec-2013.
Crossref

Joseph R. Arron, David F. Choy, Heleen Scheerens, John G. Matthews. (2013) Noninvasive Biomarkers That Predict Treatment Benefit from Biologic Therapies in Asthma. Annals of the American Thoracic Society 10:Supplement, S206-S213.
Online publication date: 6-Dec-2013.
Abstract | Full Text | PDF (785 KB) | Supplemental Material 

Prescott G. Woodruff. (2013) Subtypes of Asthma Defined by Epithelial Cell Expression of Messenger RNA and MicroRNA. Annals of the American Thoracic Society 10:Supplement, S186-S189.
Online publication date: 6-Dec-2013.
Abstract | Full Text | PDF (452 KB) | Supplemental Material 

Bart N. Lambrecht, Hamida Hammad. (2013) Asthma: The importance of dysregulated barrier immunity. European Journal of Immunology 43:12, 3125-3137.
Online publication date: 20-Nov-2013.
Crossref

Dawn C Newcomb, R Stokes Peebles. (2013) Th17-mediated inflammation in asthma. Current Opinion in Immunology 25:6, 755-760.
Online publication date: 1-Dec-2013.
Crossref

Massimo Caruso, Emanuele Crisafulli, Raffaella Lizzio, Riccardo Polosa. (2013) Biologic therapy for atopic asthma and beyond. Current Opinion in Allergy & Clinical Immunology 13:6, 677-685.
Online publication date: 1-Dec-2013.
Crossref

Jill R Johnson, Michiyoshi Nishioka, Jamila Chakir, Paul-André Risse, Ibrahim Almaghlouth, Ahmad N Bazarbashi, Sophie Plante, James G Martin, David Eidelman, Qutayba Hamid. (2013) IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respiratory Research 14:1.
Online publication date: 1-Nov-2013.
Crossref

Peng Gao, Jodie L Simpson, Jie Zhang, Peter G Gibson. (2013) Galectin-3: its role in asthma and potential as an anti-inflammatory target. Respiratory Research 14:1.
Online publication date: 9-Dec-2013.
Crossref

Guangheng Li, Ken Kikuchi, Megan Radka, Jinu Abraham, Brian P. Rubin, Charles Keller. (2013) IL-4 receptor blockade abrogates satellite cell: Rhabdomyosarcoma fusion and prevents tumor establishment. Stem Cells 31:11, 2304-2312.
Online publication date: 15-Nov-2013.
Crossref

Garry M Walsh. (2013) An Update on Biologic-Based Therapy in Asthma. Immunotherapy 5:11, 1255-1264.
Online publication date: 4-Nov-2013.
Crossref

Nicholas J. Kenyon, Jennifer M. Bratt, Joyce Lee, Juntao Luo, Lisa M. Franzi, Amir A. Zeki, Kit S. Lam, Stephania Ann Cormier. (2013) Self-Assembling Nanoparticles Containing Dexamethasone as a Novel Therapy in Allergic Airways Inflammation. PLoS ONE 8:10, e77730.
Online publication date: 25-Oct-2013.
Crossref

Jonathan Corren. (2013) Role of Interleukin-13 in Asthma. Current Allergy and Asthma Reports 13:5, 415-420.
Online publication date: 12-Sep-2013.
Crossref

Fernando D Martinez, Donata Vercelli. (2013) Asthma. The Lancet 382:9901, 1360-1372.
Online publication date: 1-Oct-2013.
Crossref

Kian Fan Chung. (2013) New treatments for severe treatment-resistant asthma: targeting the right patient. The Lancet Respiratory Medicine 1:8, 639-652.
Online publication date: 1-Oct-2013.
Crossref

Reinier R.L. Wener, Elisabeth H. Bel. (2013) Severe refractory asthma: an update. European Respiratory Review 22:129, 227-235.
Online publication date: 30-Aug-2013.
Crossref

Paul D. Robinson, Peter Van Asperen. (2013) Newer Treatments in the Management of Pediatric Asthma. Pediatric Drugs 15:4, 291-302.
Online publication date: 11-Jun-2013.
Crossref

Stephen T. Holgate. (2013) Stratified approaches to the treatment of asthma. British Journal of Clinical Pharmacology 76:2, 277-291.
Online publication date: 23-Jul-2013.
Crossref

Peter Mannon, Walter Reinisch. (2013) Republished: Interleukin 13 and its role in gut defence and inflammation. Postgraduate Medical Journal 89:1054, 448-456.
Online publication date: 16-Jul-2013.
Crossref

Marion T. Kasaian, Kimberly Marquette, Susan Fish, Charlene DeClercq, Rita Agostinelli, Timothy A. Cook, Agnes Brennan, Julie Lee, Lori Fitz, Jonathan Brooks, Yulia Vugmeyster, Cara M. M. Williams, Alan Lofquist, Lioudmila Tchistiakova. (2013) An IL-4/IL-13 Dual Antagonist Reduces Lung Inflammation, Airway Hyperresponsiveness, and IgE Production in Mice. American Journal of Respiratory Cell and Molecular Biology 49:1, 37-46.
Online publication date: 1-Jul-2013.
Abstract | Full Text | PDF (1323 KB) | Supplemental Material 

Sally Wenzel, Linda Ford, David Pearlman, Sheldon Spector, Lawrence Sher, Franck Skobieranda, Lin Wang, Stephane Kirkesseli, Ross Rocklin, Brian Bock, Jennifer Hamilton, Jeffrey E. Ming, Allen Radin, Neil Stahl, George D. Yancopoulos, Neil Graham, Gianluca Pirozzi. (2013) Dupilumab in Persistent Asthma with Elevated Eosinophil Levels. New England Journal of Medicine 368:26, 2455-2466.
Online publication date: 27-Jun-2013.
Crossref

Dawn C. Newcomb, Madison G. Boswell, Taylor P. Sherrill, Vasiliy V. Polosukhin, Kelli L. Boyd, Kasia Goleniewska, Steven L. Brody, Jay K. Kolls, Kenneth B. Adler, R. Stokes Peebles, Jr.. (2013) IL-17A Induces Signal Transducers and Activators of Transcription–6–Independent Airway Mucous Cell Metaplasia. American Journal of Respiratory Cell and Molecular Biology 48:6, 711-716.
Online publication date: 3-Jun-2013.
Abstract | Full Text | PDF (521 KB) | Supplemental Material 

Martijn J Schuijs, Monique A Willart, Hamida Hammad, Bart N Lambrecht. (2013) Cytokine targets in airway inflammation. Current Opinion in Pharmacology 13:3, 351-361.
Online publication date: 1-Jun-2013.
Crossref

Lieke W. J. van den Elsen, Yvette Nusse, Martin Balvers, Frank A. Redegeld, Edward F. Knol, Johan Garssen, Linette E. M. Willemsen. (2013) n -3 Long-chain PUFA reduce allergy-related mediator release by human mast cells in vitro via inhibition of reactive oxygen species. British Journal of Nutrition 109:10, 1821-1831.
Online publication date: 1-Oct-2012.
Crossref

S. Létuvé, C. Taillé. (2013) Physiopathologie de la réponse inflammatoire dans l’asthme de l’adulte. EMC - Pneumologie 10:2, 1-8.
Online publication date: 1-Apr-2013.
Crossref

Kai-Michael Beeh, Frank Kanniess, Frank Wagner, Cordula Schilder, Ingomar Naudts, Anya Hammann-Haenni, Joerg Willers, Hans Stocker, Philipp Mueller, Martin F. Bachmann, Wolfgang A. Renner. (2013) The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. Journal of Allergy and Clinical Immunology 131:3, 866-874.
Online publication date: 1-Mar-2013.
Crossref

Matthew C. Bell, William W. Busse. (2013) Severe Asthma: An Expanding and Mounting Clinical Challenge. The Journal of Allergy and Clinical Immunology: In Practice 1:2, 110-121.
Online publication date: 1-Mar-2013.
Crossref

Massimo Caruso, Emanuele Crisafulli, Shirin Demma, Stephen Holgate, Riccardo Polosa. (2013) Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma. Expert Opinion on Biological Therapy 13:3, 393-402.
Online publication date: 7-Jan-2013.
Crossref

William W. Busse, Sally E. Wenzel, Eli O. Meltzer, Edward M. Kerwin, Mark C. Liu, Nan Zhang, Yun Chon, Alison L. Budelsky, Joseph Lin, Shao-Lee Lin. (2013) Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients. Journal of Allergy and Clinical Immunology 131:2, 339-345.
Online publication date: 1-Feb-2013.
Crossref

Patricia C. Fulkerson, Marc E. Rothenberg. (2013) Targeting eosinophils in allergy, inflammation and beyond. Nature Reviews Drug Discovery 12:2, 117-129.
Online publication date: 21-Jan-2013.
Crossref

Edward Piper, Christopher Brightling, Robert Niven, Chad Oh, Raffaella Faggioni, Kwai Poon, Dewei She, Chris Kell, Richard D. May, Gregory P. Geba, Nestor A. Molfino. (2013) A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. European Respiratory Journal 41:2, 330-338.
Online publication date: 27-Jun-2012.
Crossref

Sabina Antonela Antoniu. (2013) Monoclonal antibodies for asthma and chronic obstructive pulmonary disease. Expert Opinion on Biological Therapy 13:2, 257-268.
Online publication date: 3-Jan-2013.
Crossref

Joseph R. Arron, Heleen Scheerens, John G. Matthews. 2013. Redefining Approaches to Asthma. Immunopharmacology, 1-49.
Crossref

Lei Zhou, Sarah A. Hoofring, Yu Wu, Thuy Vu, Peiming Ma, Steven J. Swanson, Narendra Chirmule, Marta Starcevic. (2013) Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics. The AAPS Journal 15:1, 30-40.
Online publication date: 9-Oct-2012.
Crossref

Philip M Hansbro, Grace V Scott, Ama-Tawiah Essilfie, Richard Y Kim, Malcolm R Starkey, Duc H Nguyen, Paul D Allen, Gerard E Kaiko, Ming Yang, Jay C Horvat, Paul S Foster. (2013) Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opinion on Investigational Drugs 22:1, 49-69.
Online publication date: 5-Nov-2012.
Crossref

Ankoor Shah. (2012) The Pathologic and Clinical Intersection of Atopic and Autoimmune Disease. Current Allergy and Asthma Reports 12:6, 520-529.
Online publication date: 17-Aug-2012.
Crossref

Russell S. Traister, Sally E. Wenzel. (2012) Inflammatory phenotypes in asthma pathogenesis. Drug Discovery Today: Disease Mechanisms 9:3-4, e75-e81.
Online publication date: 1-Dec-2012.
Crossref

Girolamo Pelaia, Alessandro Vatrella, Rosario Maselli. (2012) The potential of biologics for the treatment of asthma. Nature Reviews Drug Discovery 11:12, 958-972.
Online publication date: 30-Nov-2012.
Crossref

Richard B. Moss. (2012) The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Annals of the New York Academy of Sciences 1272:1, 49-57.
Online publication date: 11-Dec-2012.
Crossref

Tsuyoshi Tanabe, Henry J Rozycki, Soichiro Kanoh, Bruce K Rubin. (2012) Cardiac asthma: new insights into an old disease. Expert Review of Respiratory Medicine 6:6, 705-714.
Online publication date: 9-Jan-2014.
Crossref

Sue‐Jane Wang, H. M. James Hung, Robert O'Neill. (2012) Paradigms for adaptive statistical information designs: practical experiences and strategies. Statistics in Medicine 31:25, 3011-3023.
Online publication date: 24-Aug-2012.
Crossref

Jennifer L. Ingram, Monica Kraft. (2012) IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies. Journal of Allergy and Clinical Immunology 130:4, 829-842.
Online publication date: 1-Oct-2012.
Crossref

Tania Maes, Guy F. Joos, Guy G. Brusselle. (2012) Targeting Interleukin-4 in Asthma: Lost in Translation?. American Journal of Respiratory Cell and Molecular Biology 47:3, 261-270.
Online publication date: 14-Dec-2012.
Abstract | Full Text | PDF (864 KB) 

Christopher Chang. (2012) Asthma in Children and Adolescents: A Comprehensive Approach to Diagnosis and Management. Clinical Reviews in Allergy & Immunology 43:1-2, 98-137.
Online publication date: 29-Mar-2011.
Crossref

Mark Ballow, Cezmi A. Akdis, Thomas B. Casale, Andrew J. Wardlaw, Sally E. Wenzel, Zuhair Ballas, Jan Lötvall. (2012) Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. Journal of Allergy and Clinical Immunology 130:2, 311-324.
Online publication date: 1-Aug-2012.
Crossref

Michael J. Holtzman. (2012) Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. Journal of Clinical Investigation 122:8, 2741-2748.
Online publication date: 1-Aug-2012.
Crossref

David Gibeon, Andrew N Menzies-Gow. (2012) Targeting interleukins to treat severe asthma. Expert Review of Respiratory Medicine 6:4, 423-439.
Online publication date: 9-Jan-2014.
Crossref

Riccardo Polosa, Thomas Casale. (2012) Monoclonal antibodies for chronic refractory asthma and pipeline developments. Drug Discovery Today 17:11-12, 591-599.
Online publication date: 1-Jun-2012.
Crossref

Glenn J. Whelan. 2012. Monoclonal Antibodies in the Treatment of Asthma. Antibody‐Mediated Drug Delivery Systems, 457-472.
Crossref

Stephen T. Holgate. (2012) Trials and tribulations in identifying new biologic treatments for asthma. Trends in Immunology 33:5, 238-246.
Online publication date: 1-May-2012.
Crossref

Sally E Wenzel. (2012) Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Medicine 18:5, 716-725.
Online publication date: 4-May-2012.
Crossref

Cezmi A Akdis. (2012) Therapies for allergic inflammation: refining strategies to induce tolerance. Nature Medicine 18:5, 736-749.
Online publication date: 4-May-2012.
Crossref

P. M. O'Byrne, N. Naji, G. M. Gauvreau. (2012) Severe asthma: future treatments. Clinical & Experimental Allergy 42:5, 706-711.
Online publication date: 20-Apr-2012.
Crossref

A. H. Poon, D. H. Eidelman, J. G. Martin, C. Laprise, Q. Hamid. (2012) Pathogenesis of severe asthma. Clinical & Experimental Allergy 42:5, 625-637.
Online publication date: 20-Apr-2012.
Crossref

RD May, PD Monk, ES Cohen, D Manuel, F Dempsey, NHE Davis, AJ Dodd, DJ Corkill, J Woods, C Joberty‐Candotti, LA Conroy, F Koentgen, EC Martin, R Wilson, N Brennan, J Powell, IK Anderson. (2012) Preclinical development of CAT‐354, an IL‐13 neutralizing antibody, for the treatment of severe uncontrolled asthma. British Journal of Pharmacology 166:1, 177-193.
Online publication date: 10-Apr-2012.
Crossref

Shoichiro Ohta, Rumiko Shibata, Yoshifumi Nakao, Yoshinori Azuma, Kazuto Taniguchi, Kazuhiko Arima, Shoichi Suzuki, Hiroshi Shiraishi, Tsuyoshi Iwasaka, Kenji Izuhara. (2012) The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 49:3, 277-284.
Online publication date: 8-Mar-2012.
Crossref

Steven G Smith, Brittany Watson, Gordon Clark, Gail M Gauvreau. (2012) Eculizumab for treatment of asthma. Expert Opinion on Biological Therapy 12:4, 529-537.
Online publication date: 13-Mar-2012.
Crossref

Garry M Walsh. (2012) An update on emerging drugs for asthma. Expert Opinion on Emerging Drugs 17:1, 37-42.
Online publication date: 31-Jan-2012.
Crossref

Tracey L. Bonfield, Kristie R. Ross. (2012) Asthma heterogeneity and therapeutic options from the clinic to the bench. Current Opinion in Allergy & Clinical Immunology 12:1, 60-67.
Online publication date: 1-Feb-2012.
Crossref

Dawn C. Newcomb, Madison G. Boswell, Matthew M. Huckabee, Kasia Goleniewska, Daniel E. Dulek, Sara Reiss, Nicholas W. Lukacs, Jay K. Kolls, R. Stokes Peebles. (2012) IL-13 Regulates Th17 Secretion of IL-17A in an IL-10–Dependent Manner. The Journal of Immunology 188:3, 1027-1035.
Online publication date: 1-Feb-2012.
Crossref

Dhananjay Desai, Christopher Brightling. 2012. Cytokines and Cytokine-Specific Therapy in Asthma. Advances in Clinical Chemistry, 57-97.
Crossref

Andrew Bush. 2012. Severe Asthma. Kendig & Chernickâs Disorders of the Respiratory Tract in Children, 736-743.
Crossref

Peter J. Barnes. (2012) Severe asthma: Advances in current management and future therapy. Journal of Allergy and Clinical Immunology 129:1, 48-59.
Online publication date: 1-Jan-2012.
Crossref

Gabriella Papale, Riccardo Polosa. 2012. Biologics therapies for severe asthma. Advances in Asthma Management, 182-195.
Crossref

Giovanni Passalacqua. 2012. Emerging therapeutics and future direction. Advances in Asthma Management, 168-181.
Crossref

June-Hyuk Lee. (2012) Novel Drugs for Asthma Treatment: Immunomodulatory Therapy. Korean Journal of Medicine 83:2, 190.
Online publication date: 1-Jan-2012.
Crossref

Harald Renz, Ingo B. Autenrieth, Per Brandtzæg, William O. Cookson, Stephen Holgate, Erika von Mutius, Rudolf Valenta, Dirk Haller. (2011) Gene-environment interaction in chronic disease: A European Science Foundation Forward Look. Journal of Allergy and Clinical Immunology 128:6, S27-S49.
Online publication date: 1-Dec-2011.
Crossref

Matthew C. Catley, Julie Coote, Mohamed Bari, Kate L. Tomlinson. (2011) Monoclonal antibodies for the treatment of asthma. Pharmacology & Therapeutics 132:3, 333-351.
Online publication date: 1-Dec-2011.
Crossref

Stephen T. Holgate. (2011) Asthma: a simple concept but in reality a complex disease. European Journal of Clinical Investigation 41:12, 1339-1352.
Online publication date: 26-May-2011.
Crossref

Berislav Bosnjak, Barbara Stelzmueller, Klaus J Erb, Michelle M Epstein. (2011) Treatment of allergic asthma: Modulation of Th2 cells and their responses. Respiratory Research 12:1.
Online publication date: 1-Dec-2011.
Crossref

Rodolfo M. Pascual, Stephen P. Peters. (2011) Asthma. Medical Clinics of North America 95:6, 1115-1124.
Online publication date: 1-Nov-2011.
Crossref

Tarundeep Kakkar, Cynthia Sung, Leonid Gibiansky, Thuy Vu, Adimoolam Narayanan, Shao-Lee Lin, Michael Vincent, Christopher Banfield, Alex Colbert, Sarah Hoofring, Marta Starcevic, Peiming Ma. (2011) Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor. Pharmaceutical Research 28:10, 2530-2542.
Online publication date: 21-May-2011.
Crossref

Cailong Fang, Chris J Corrigan, Sun Ying. (2011) Identifying and testing potential new anti-asthma agents. Expert Opinion on Drug Discovery 6:10, 1027-1044.
Online publication date: 6-Sep-2011.
Crossref

Kevin Mullane. (2011) Asthma translational medicine: Report card. Biochemical Pharmacology 82:6, 567-585.
Online publication date: 1-Sep-2011.
Crossref

Stephen T. Holgate. (2011) Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?. Journal of Allergy and Clinical Immunology 128:3, 495-505.
Online publication date: 1-Sep-2011.
Crossref

Marsha Wills‐karp. 2011. Role of Th2 Cells in the Allergic Diathesis. Inflammation and Allergy Drug Design, 15-25.
Crossref

Shamsah Kazani, Elliot Israel. (2011) Update in Asthma 2010. American Journal of Respiratory and Critical Care Medicine 184:3, 291-296.
Online publication date: 14-Dec-2012.
First Page | Full Text | PDF (95 KB) 

Anthony M. Holmes, Roberto Solari, Stephen T. Holgate. (2011) Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discovery Today 16:15-16, 659-670.
Online publication date: 1-Aug-2011.
Crossref

Sherif Gonem, Dhananjay Desai, Salman Siddiqui, Christopher C.E. Brightling. (2011) Evidence for phenotype-driven treatment in asthmatic patients. Current Opinion in Allergy & Clinical Immunology 11:4, 381-385.
Online publication date: 1-Aug-2011.
Crossref

Hongwei Yao, Irfan Rahman. 2011. Environment and the Role of Inflammation in Chronic Pulmonary Diseases. Inflammation, Lifestyle and Chronic Diseases.
Crossref

Tran‐Hoai T. Nguyen, Thomas B. Casale. (2011) Immune modulation for treatment of allergic disease. Immunological Reviews 242:1, 258-271.
Online publication date: 20-Jun-2011.
Crossref

Jaymin B. Morjaria, Jack A. Kastelik. (2011) Unusual asthma syndromes and their management. Therapeutic Advances in Chronic Disease 2:4, 249-264.
Online publication date: 7-Jun-2011.
Crossref

Salvatore Clienti, Jaymin B. Morjaria, Elisa Basile, Riccardo Polosa. (2011) Monoclonal Antibodies for the Treatment of Severe Asthma. Current Allergy and Asthma Reports 11:3, 253-260.
Online publication date: 1-Mar-2011.
Crossref

Pierre-Olivier Girodet, Annaig Ozier, Imane Bara, Jose-Manuel Tunon de Lara, Roger Marthan, Patrick Berger. (2011) Airway remodeling in asthma: New mechanisms and potential for pharmacological intervention. Pharmacology & Therapeutics 130:3, 325-337.
Online publication date: 1-Jun-2011.
Crossref

Rik JB Loymans, Gerben ter Riet, Peter J Sterk. (2011) Definitions of asthma exacerbations. Current Opinion in Allergy & Clinical Immunology 11:3, 181-186.
Online publication date: 1-Jun-2011.
Crossref

Louanne M. Tourangeau, Arthur Kavanaugh, Stephen I. Wasserman. (2011) The role of monoclonal antibodies in the treatment of severe asthma. Therapeutic Advances in Respiratory Disease 5:3, 183-194.
Online publication date: 10-Mar-2011.
Crossref

Tran-Hoai T. Nguyen, Jeffrey R. Stokes, Thomas B. Casale. (2011) Future Forms of Immunotherapy and Immunomodulators in Allergic Disease. Immunology and Allergy Clinics of North America 31:2, 343-365.
Online publication date: 1-May-2011.
Crossref

Rachel M. McLoughlin, Kingston H.G. Mills. (2011) Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. Journal of Allergy and Clinical Immunology 127:5, 1097-1107.
Online publication date: 1-May-2011.
Crossref

Philip M Hansbro, Gerard E Kaiko, Paul S Foster. (2011) Cytokine/anti‐cytokine therapy – novel treatments for asthma?. British Journal of Pharmacology 163:1, 81-95.
Online publication date: 6-Apr-2011.
Crossref

Tohru Hosoyama, Mohammed Imran Aslam, Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Joel E. Michalek, Lee Ann Zarzabal, Laura D. Nelon, Denis C. Guttridge, Brian P. Rubin, Charles Keller. (2011) IL-4R Drives Dedifferentiation, Mitogenesis, and Metastasis in Rhabdomyosarcoma. Clinical Cancer Research 17:9, 2757-2766.
Online publication date: 1-May-2011.
Crossref

Gail M. Gauvreau, Louis-Philippe Boulet, Donald W. Cockcroft, J. Mark FitzGerald, Chris Carlsten, Beth E. Davis, Francine Deschesnes, MyLinh Duong, Billie L. Durn, Karen J. Howie, Linda Hui, Marion T. Kasaian, Kieran J. Killian, Tara X. Strinich, Richard M. Watson, Nathalie Y, Simon Zhou, Donald Raible, Paul M. O'Byrne. (2011) Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma. American Journal of Respiratory and Critical Care Medicine 183:8, 1007-1014.
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (1261 KB) 

Dawn C. Newcomb, Madison G. Boswell, Weisong Zhou, Matthew M. Huckabee, Kasia Goleniewska, Carla M. Sevin, Gurjit K. Khurana Hershey, Jay K. Kolls, R. Stokes Peebles. (2011) Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production. Journal of Allergy and Clinical Immunology 127:4, 1006-1013.e4.
Online publication date: 1-Apr-2011.
Crossref

Jaymin B Morjaria, Maria Proiti, Riccardo Polosa. (2011) Stratified medicine in selecting biologics for the treatment of severe asthma. Current Opinion in Allergy & Clinical Immunology 11:1, 58-63.
Online publication date: 1-Feb-2011.
Crossref

(2011) Current World Literature. Current Opinion in Allergy & Clinical Immunology 11:1, 64-68.
Online publication date: 1-Feb-2011.
Crossref

David F. Choy, Barmak Modrek, Alexander R. Abbas, Sarah Kummerfeld, Hilary F. Clark, Lawren C. Wu, Grazyna Fedorowicz, Zora Modrusan, John V. Fahy, Prescott G. Woodruff, Joseph R. Arron. (2011) Gene Expression Patterns of Th2 Inflammation and Intercellular Communication in Asthmatic Airways. The Journal of Immunology 186:3, 1861-1869.
Online publication date: 1-Feb-2011.
Crossref

Sabine Flicker, Elisabeth Gadermaier, Christoph Madritsch, Rudolf Valenta. 2011. Passive Immunization with Allergen-Specific Antibodies. Vaccines against Allergies, 141-159.
Crossref

Jonathan Corren. (2011) Cytokine inhibition in severe asthma: current knowledge and future directions. Current Opinion in Pulmonary Medicine 17:1, 29-33.
Online publication date: 1-Jan-2011.
Crossref

(2011) Current World Literature. Current Opinion in Pulmonary Medicine 17:1, 50-53.
Online publication date: 1-Jan-2011.
Crossref

Jae Youn Cho. (2011) Recent Advances in Mechanisms and Treatments of Airway Remodeling in Asthma: A Message from the Bench Side to the Clinic. The Korean Journal of Internal Medicine 26:4, 367.
Online publication date: 1-Jan-2011.
Crossref

Douglas S. Robinson. (2010) The role of the T cell in asthma. Journal of Allergy and Clinical Immunology 126:6, 1081-1091.
Online publication date: 1-Dec-2010.
Crossref

Andrew Bush, Sejal Saglani. (2010) Management of severe asthma in children. The Lancet 376:9743, 814-825.
Online publication date: 1-Sep-2010.
Crossref

William A Sewell. (2010) Progress towards anticytokine therapy in asthma. Immunotherapy 2:5, 651-654.
Online publication date: 29-Sep-2010.
Crossref

Larry Borish. (2010) IL-4 and IL-13 Dual Antagonism. American Journal of Respiratory and Critical Care Medicine 181:8, 769-770.
Online publication date: 20-Dec-2012.
First Page | Full Text | PDF (511 KB) 

C. K. Oh, G. P. Geba, N. Molfino. (2010) Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. European Respiratory Review 19:115, 46-54.
Online publication date: 28-Feb-2010.
Crossref

Marisha L. Cook, Bruce S. Bochner. (2010) Update on Biological Therapeutics for Asthma. World Allergy Organization Journal 3:6, 188-194.
Online publication date: 1-Jan-2010.
Crossref